Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao in Diabetic Foot Ulcer
NCT06197412Phase 4Recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Yunnan Baiyao Ointment + New Rubber Patch in diabetic foot ulcer (DFU) (6 arms), sponsored by Peking University Third Hospital. Primary endpoint: 2-week reduction rate of wound area. Started Dec 2023; status: recruiting.
02
Drugs
Yunnan Baiyao Ointment + New Rubber Patch
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06197412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06197412.